Effect of a fat spread enriched with medium-chain triacylglycerols and a special fatty acid-micronutrient combination on cardiometabolic risk factors in overweight patients with diabetes

Nutrition and Metabolism

Volumn 8, Issue , 2011, Pages

  Siener, Roswitha ^a   Ehrhardt, Christina ^b   Bitterlich, Norman ^c   Metzner, Christine ^b,d  

^a UNIVERSITY OF BONN   (Germany)

^b Bonn Education Association for Dietetics R A   (Germany)

^c Department of Biostatistics   (Germany)

^d UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; LONG CHAIN FATTY ACID; MEDIUM CHAIN TRIACYLGLYCEROL; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; BLOOD ANALYSIS; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFECT; FAT INTAKE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRIENT; OBESITY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS; URINE PH; WAIST CIRCUMFERENCE;

EID: 79953759265     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-8-21     Document Type: Article

References (30)

1. Signalling role of adipose tissue: adipokines and inflammation in obesity. P Trayhurn IS Wood, Biochem Soc Trans 2005 33 1078 1081 10.1042/BST20051078 16246049 (Pubitemid 41659117)
2. Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration. HS Kahn R Valdez, Am J Clin Nutr 2003 78 928 934 14594778 (Pubitemid 39663468)
3. Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes. S Sam S Haffner MH Davidson RB D'Agostino S Feinstein G Kondos A Perez T Mazzone, Diabetes Care 2009 32 1916 1620 10.2337/dc09-0412 19592623
4. The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program-Adult Treatment Panel III and International Diabetes Federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile. P Blackburn I Lemieux N Alméras J Bergeron M Cote A Tremblay B Lamarche JP Despres, Metabolism 2009 58 1123 1130 10.1016/j.metabol.2009.03.012 19481769
5. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Circulation 2002 106 3143 3421 12485966
6. Low-grade inflammation in individuals with the hypertriglyceridemic waist phenotype: another feature of the atherogenic dysmetabolism. O Rogowski I Shapira A Steinvil S Berliner, Metabolism 2009 58 661 667 10.1016/j.metabol. 2009.01.005 19375589
7. High-sensitivity C-reactive protein and the hypertriglyceridemic waist in patients with type 2 diabetes and metabolic syndrome. H Rosolova B Petrlova J Simon P Sifalda I Sipova, Med Sci Monit 2008 14 R411 415 18667998
8. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. JW Baynes SR Thorpe, Diabetes 1999 48 1 9 10.2337/diabetes.48. 1.1 9892215 (Pubitemid 29019345)
9. The relationship between chronic glycaemic control and oxidative stress in type 2 diabetes mellitus. PH Whiting A Kalansooriya I Holbrook F Haddad PE Jennings, Br J Biomed Sci 2008 65 71 74 19055108 (Pubitemid 351913978)
10. The usefulness of dietary medium-chain triglycerides in body weight control: fact or fancy? AC Bach Y Ingenbleek A Frey, J Lipid Res 1996 37 708 726 8732772 (Pubitemid 26140809)
11. Short term effects of dietary medium-chain fatty acids and n-3 long-chain polyunsaturated fatty acids on the fat metabolism of healthy volunteers. C Beermann J Jelinek T Reinecker A Hauenschild G Boehm HU Kloer, Lipids Health Dis 2003 2 1 10 10.1186/1476-511X-2-10 12689340 (Pubitemid 38809228)
12. Medium-chain-triglyceride lipid emulsion: Metabolism and tissue distribution. RC Johnson SK Young R Cotter L Lin WB Rowe, Am J Clin Nutr 1990 52 502 508 2118303
13. Postprandial thermogenesis in lean and obese subjects after meals supplemented with medium-chain and long-chain triglycerides. L Scalfi A Coltorti F Contaldo, Am J Clin Nutr 1991 53 1130 1133 2021124
14. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. Y Adkins DS Kelly, J Nutr Biochem 2010 21 781 792 10.1016/j.jnutbio.2009.12.004 20382009
15. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. PM Kris-Etherton WS Harris LJ Appel, Circulation 2002 106 2747 2757 10.1161/01.CIR.0000038493.65177.94 12438303 (Pubitemid 35364932)
16. N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination. M Zeman A Zak M Vecka E Tvrzicka A Pisarikova B Stankova, J Nutr Biochem 2006 17 379 384 10.1016/j.jnutbio.2005.08.007 16214329 (Pubitemid 43729351)
17. Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes. J Hartweg AJ Farmer R Perera RR Holman HAW Neil, Diabetologia 2007 50 1593 1602 10.1007/s00125-007-0695-z 17541540 (Pubitemid 47036644)
18. Vitamin D supplementation enhances beneficial effects of weight loss on cardiovascular risk markers. A Zittermann S Frisch HK Berthold C Goetting J Kuhn K Kleesiek P Stehle H Koertke R Koerfer, Am J Clin Nutr 2009 89 1321 1327 10.3945/ajcn.2008.27004 19321573
19. Effect of long-term treatment with antioxidants (vitamin C, vitamin E, coenzyme Q10 and selenium) on arterial compliance, humoral factors, and inflammatory markers in patients with multiple cardiovascular risk factors. M Shargorodsky O Debby Z Matas R Zimlichman, Nutr Metab 2010 7 55 10.1186/1743-7075-7-55
20. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. AS Levey J Coresh T Greene J Marsh LA Stevens JW Kusek F Van Lente, Clin Chem 2007 53 766 772 10.1373/clinchem.2006.077180 17332152 (Pubitemid 46580250)
21. Effects of margarine containing medium-chain triacylglycerols on body fat reduction in humans. N Nosaka H Maki Y Suzuki H Haruna A Ohara M Kasai H Tsuji A Toshiaki M Okazaki O Igarashi K Kondo, J Atheroscler Thromb 2003 10 290 298 14718746
22. A good response to oil with medium- and long-chain fatty acids in body fat and blood lipid profiles of male hypertriglyceridemic subjects. Y Liu J Wang R Zhang Y Zhang Q Xu J Zhang Y Zhang Z Zheng X Yu H Jing N Nosaka M Kasai T Aoyama J Wu C Xue, Asia Pac J Clin Nutr 2009 18 351 358 19786383
23. Dietary medium-chain triacylglycerols suppress accumulation of body fat in a double-blind, controlled trial in healthy men and women. H Tsuji M Kasai H Takeuchi M Nakamura M Okazaki K Kondo, J Nutr 2001 131 2853 2859 11694608 (Pubitemid 33063114)
24. Feeding behavior in rats fed diets containing medium chain triglyceride. M Furuse YH Choi RT Mabayo JI Okumura, Physiol Behav 1992 52 815 817 10.1016/0031-9384(92)90419-3 1409958
25. Medium-chain triglycerides increase energy expenditure and decrease adiposity in overweight men. MP St-Onge R Ross WD Parsons PJH Jones, Obes Res 2003 11 395 402 10.1038/oby.2003.53 12634436 (Pubitemid 41151627)
26. Twenty-four-hour energy expenditure and urinary catecholamines of humans consuming low-to-moderate amounts of medium-chain triglycerides: a dose-response study in a human respiratory chamber. AG Dulloo M Fathi N Mensi L Giardier, Eur J Clin Nutr 1996 50 152 158 8654328
27. Customary use of plant sterol and plant stanol enriched margarine is associated with changes in serum plant sterols and stanol concentrations in humans. HP Fransen N de Jong M Wolfs H Verhagen WMM Verschuren D Lütjohann K von Bergmann J Plat RP Mensink, J Nutr 2007 137 1301 1306 17449596 (Pubitemid 46701926)
28. Carob pulp preparation rich in insoluble fiber lowers total and LDL cholesterol in hypercholesterolemic patients. HJF Zunft W Lüder A Harde B Haber HJ Graubaum C Koebnick J Grünwald, Eur J Nutr 2003 42 235 242 10.1007/s00394-003-0438-y 14569404 (Pubitemid 37243582)
29. The possible antiketogenic and gluconeogenic effects of the beta-oxidation of fatty acids in rats. PB Mortensen, Biochim Biophys Acta 1980 620 177 185 7437451 (Pubitemid 11216237)
30. Excretion of dicarboxylic acids following administration if medium chain triglycerides. LAM Lima OP Gray H Losty, J Parenter Enteral Nutr 1987 11 600 601 10.1177/0148607187011006600